Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Ebola Patient Who Received Aethlon Medical Hemopurifier Therapy Has Been Discharged From Hospital

November 24, 2014 – 5:00 pm | Edit Post

Ebola Patient Who Received Aethlon Hemopurifier Therapy Has Been Discharged From HospitalSAN DIEGO, Nov. 25, 2014 /PRNewswire/ –Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, disclosed…

University of California, San Francisco (UCSF) And OncoSec Medical Inc. Collaborate To Evaluate Investigational Combination Of ImmunoPulse And Anti-PD-1 Treatment

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, has entered a clinical collaboration with the University of California, San Francisco (UCSF), to evaluate the safety, tolerability and efficacy of the combination of KEYTRUDA (pembrolizumab), Mercks anti-PD-1 therapy, and OncoSecs ImmunoPulse (intratumoral IL-12) in…

Receptos Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares And Completion Of Underwritten Public Offering Of Common Stock

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 24, 2014 (GLOBE NEWSWIRE) — Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced today the completion of the previously announced underwritten public offering of an aggregate of 4…

Arena Pharmaceuticals, Inc. Issued Composition Of Matter Patent By United States Patent And Trademark Office For Ralinepag And Related Compounds

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ –Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the US Patent and Trademark Office granted Arena U.S. Patent No. 8,895,776, entitled “Modulators of the Prostacyclin (PGI2) Receptor Useful for the Treatment of Disorders Related Thereto,” covering ralinepag…

ACADIA Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the following investor conferences:•The Piper Jaffray 26th Annual Healthcare Conference on Tuesday, December 2, 20…

Volcano Corporation Presentation At Piper Jaffray Conference To Be Webcast

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ — Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today…

Sequenom Inc. Announces Participation At The 26th Annual Piper Jaffray Healthcare Conference

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ –Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company’s participation at the 2014 Piper Jaffray Healthcare Conference at the New York Palace Hotel in New York, NY

First Angioedema Treatment Center Opens at UC San Diego Health System

November 24, 2014 – 2:28 pm | Edit Post

UC San Diego Health System in partnership with the U.S. Hereditary Angioedema Association (HAEA), a non-profit patient advocacy organization, has opened the nation’s first dedicated center for diagnosing and treating diverse forms of swelling, known collectively as angioedema.

NuVasive to Participate in Investor Events in December 2014

November 24, 2014 – 2:05 pm | Edit Post

SAN DIEGO, CA–(Marketwired – Nov 24, 2014) – NuVasive, Inc. ( NASDAQ : NUVA ), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor events in December 2014:

Peptic ulcer, cancer bacteria therapy discovery

November 24, 2014 – 1:00 pm | Edit Post

Vegetable oil ingredient may provide cheap way to control infection billions have.